BL
RMD icon

Balentine LLC’s ResMed RMD Stock Holding History

Balentine LLC’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,072
Closed -$608K – 483
2024
Q1 		$608K Buy
3,072
+562
+22% +$103K 0.02% 255
2023
Q4 		$432K Buy
+2,510
New +$386K 0.01% 310
2023
Q3 		– Sell
-1,082
Closed -$236K – 593
2023
Q2 		$236K Buy
+1,082
New +$241K 0.01% 440
2022
Q4 		– Sell
-993
Closed -$217K – 693
2022
Q3 		$217K Sell
993
-48
-5% -$10.9K 0.01% 473
2022
Q2 		$218K Sell
1,041
-178
-15% -$37.9K 0.01% 519
2022
Q1 		$296K Buy
+1,219
New +$295K 0.01% 432
2020
Q3 		– Sell
-100
Closed -$19K – 699
2020
Q2 		$19K Sell
100
-131
-57% -$21.4K ﹤0.01% 409
2020
Q1 		$34K Buy
231
+222
+2,467% +$35.4K ﹤0.01% 211
2019
Q4 		$1K Buy
9
+3
+50% +$432 ﹤0.01% 589
2019
Q3 		$1K Hold
6
– – ﹤0.01% 714
2019
Q2 		$1K Buy
+6
New +$665 ﹤0.01% 733

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Balentine LLC's RMD Position: Q2 2024 in Review

Balentine LLC sold out of ResMed (RMD) in Q2 2024, closing a stake of 3,072 shares — an estimated $608K sold.

Balentine LLC first reported a position in RMD in Q2 2019 and held it in 11 quarters. The position peaked at $608K in Q1 2024. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Balentine LLC reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 3,072 ResMed shares in Q2 2024, an estimated $608K.
  • Balentine LLC first reported a position in ResMed in Q2 2019 and held it in 11 quarters.
  • Balentine LLC's ResMed position peaked at $608K in Q1 2024.
  • 771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.